Healthcare Realty Trust (HR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
30 Apr, 2026Portfolio overview and financial performance
Owns 563 outpatient medical properties totaling 33 million sq. ft. with a $10.6B enterprise value and $6.4B market cap.
Achieved 1Q 2026 normalized FFO per share of $0.41, up 5% YoY, and same store cash NOI growth of 6.9%.
Maintains 92.3% same store occupancy and 93.5% tenant retention, with 2.0M sq. ft. of lease executions and average lease term of 7.7 years.
Increased 2026 normalized FFO per share guidance to $1.59–$1.65 and raised same store cash NOI growth guidance to 3.75%–4.75%.
Net debt to adjusted EBITDA stands at 5.5x, with $1.2B in liquidity and a BBB/Baa2 credit rating.
Strategic initiatives and capital allocation
Completed $1.2B of planned 2025 dispositions at a blended 6.7% cap rate, exiting 14 non-core markets.
Repurchased $100M of common stock in 1Q 2026 and completed new JV acquisition for $89M.
Added two new redevelopment projects with an expected cost of $31M and received $400M in commitments for a new unsecured term loan.
Right-sized quarterly dividend to $0.24/share, saving ~$100M annually, and returned $385M to shareholders in 2025 via dividends.
Redevelopment portfolio is 60% leased, with ~1,000bps improvement since 3Q 2025 and targeted incremental yields of 9–12%.
Market positioning and sector trends
Only REIT focused exclusively on the outpatient medical sector, benefiting from aging demographics and limited new supply.
Sector occupancy at 93%, highest in over 7 years, with market rent growth above 3% and record rent escalators.
Private markets recognize value, with ~$10B average annual investment volume and attractive risk-adjusted returns.
Portfolio concentrated in top 50 MSAs, with deep relationships with leading national and regional health systems.
Improved portfolio quality post-dispositions, with current portfolio occupancy at 92% and better market demographics.
Latest events from Healthcare Realty Trust
- Record leasing and 6.9% NOI growth drove raised guidance and $100M in share repurchases.HR
Q1 20265 May 2026 - Director elections, auditor ratification, and say-on-pay headline the 2026 annual meeting.HR
Proxy filing7 Apr 2026 - Board recommends approval of director nominees, auditor, and executive compensation; strong ESG focus.HR
Proxy filing7 Apr 2026 - Strong leasing, $1.2B asset sales, and improved leverage drive positive 2025 and 2026 outlook.HR
Q4 202513 Feb 2026 - Q2 net loss on impairments, but strong leasing, asset sales, and FFO guidance affirmed.HR
Q2 20242 Feb 2026 - Normalized FFO per share rose 1.2% as leasing, asset sales, and share buybacks drove activity.HR
Q3 202417 Jan 2026 - Record leasing, robust FFO growth, and deleveraging highlight 2024 performance.HR
Q4 202429 Dec 2025 - Normalized FFO per share was $0.39 in Q1 2025, with improved net loss and strong leasing.HR
Q1 202527 Dec 2025 - Board recommends approval of all proposals, with strong focus on pay-for-performance and ESG.HR
Proxy Filing1 Dec 2025